Joint Press Briefing of NAFDAC and PCN on Coordinated Wholesale Centre in Kano- November 2024
PRESS BRIEF PROF MOJISOLA CHRISTIANAH ADEYEYE, DIRECTOR GENERAL, NATIONAL AGENCY FOR FOOD AND DRUG ADMINISTRATION AND CONTROL (NAFDAC) AND THE REGISTRAR, PHARM IBRAHIM BABASHEHU AHMED, PHARMACY COUNCIL OF NIGERIA ON RELOCATION OF OPEN DRUG MARKETERS TO COORDINATED WHOLESALE CENTRE (CWC) IN KANO: TO MAKE NIGERIANS HEALTHIER: CONTINUED FIGHT AGAINST SUBSTANDARD AND FALSIFIED MEDICINES (SFS) STATUS […]
Public Alert No. 047/2024 -Alert Recall Of Acetazolamide Tablets Usp 125mg, Manufactured By Rubicon Research Private Ltd
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public of the recall of Acetazolamide Tablets usp 125mg manufactured by an American pharmaceutical company, Rubicon Research Private Ltd, with batch number 30575HF1. The company recalled the affected lot due to contamination, dirty and discoloured tablets. Acetazolamide is a potent carbonic […]
Public Alert No. 046/2024 -Alert on Recall of Two Batches of Pantogen Injection “Singtong” by Taiwanese FDA
The National Agency for Food and Drug Administration and Control (NAFDAC) is notifying the healthcare providers of the recall of two (2) batches of Pantogen Injection “Sintong” by the Taiwanese FDA, with (Lot numbers 4DM1150 and 4DM0442), produced by Xindong Biotech Co. Ltd. The recall was initiated by the manufacturer following received customer complaints of […]
Public Alert No. 045/2024 – Alert on the Ban of Brominated Vegetable oil (BVO) used to suspend citrus flavourings into sodas and juice drinks
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public that the U.S. Food and Drug Administration (FDA) has revoked the regulation authorizing the use of brominated vegetable oil (BVO) in food. Brominated vegetable oil, or BVO, is vegetable oil modified with bromine. It’s used to suspend citrus flavourings into sodas and […]
Public Alert No. 044/2024 – Alert on Weight Loss Products Containing Banned Substances
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public that the Malaysian Ministry of Health and Singapore Food Agency (SFA), has warned against the use of three(3) food products marketed for weight loss, Lemo A Detox slimming sachets, Lemo S Detox slimming sachets, and Lemo D Detox slimming sachets. […]
List of Products Withdrawn by NAFDAC
This is to inform the General Public that the following list of products are approved for withdrawal, suspension and cancellation by NAFDAC. They are therefore no longer permitted for manufacture, importation, exportation, distribution, advertisement, sale and use within Nigeria. Was this helpful? Yes No Submit Cancel Thanks for your feedback!
Note to Industry on Requirement for Bioequivalence Study
Bioequivalence (BE) study is a clinical trial designed to demonstrate that two pharmaceutical products, typically a generic drug and its corresponding reference innovator brand have similar bioavailability and efficacy hence, interchangeable healthcare practices. Over 90% of drug products used in the country are generics with which access and affordability is created without compromising quality. Presently, […]
Opening Remarks by Prof. Mojisola Christianah Adeyeye, at the World Antimicrobial Awareness Week (WAAW) 2024 Titled Educate, Advocate, Act Now
Opening Remark By Prof. Adeyeye C. M Director General NAFDAC Antimicrobial Awareness Week (WAAW): Educate, Advocate, Act Now Lagos, Nigeria 21st November, 2024. PROTOCOL It is my privilege to welcome you to this year’s World Antimicrobial Awareness Week (WAAW) titled; Educate. Advocate. Act Now. This week provides the Agency an opportunity to raise awareness about […]
Building A Strong Bioequivalence Study Ecosystem in Nigeria
The investigation of bioequivalence of drugs involves the comparison of the rate and extent of active ingredient absorption between the generic product and the innovator’s brands. This comparison is usually performed through clinical trials in human subjects or through in vitro studies using simulated biological fluids. The results of these studies provide the basis for […]
Public Alert No. 043/2024 – Alert on the Sale of Counterfeit COMBIART (Artemether + Lumefantrine 20/120mg) Dispersible Tablet in Nigeria
The National Agency for Food and Drugs Administration and Control (NAFDAC) is writing to inform the public about the circulation of counterfeit Combiart Dispersible Tablet 20/120mg in the country. The product is manufactured by Strides Arcolab Limited, based in India. This product was discovered in the FCT and Rivers State, during surveillance activities conducted by […]
